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Introduction
Prostatorectal fistulae are rare complications following
radiotherapy as a curative or palliative therapy for pros-
tate cancer. Although fecal and urinary diversions are
appropriate considerations for conservative treatment,
the catheter applied for suprapubic cystostomy may
induce intractable perianal or bladder pain with poor
drainage in some patients. Therefore, we developed a
modified suprapubic catheter for patients with prosta-
torectal fistula and intractable catheter-associated pain.
Case Report
A 70-year-old patient with stage cT1cN0M0 prostate
cancer and Gleason grade 3+3 received 3-dimensional
conformation external beam radiotherapy (72 Gy) as
curative therapy in June 2000. The early post-therapy
course was smooth, and serum prostate-specific antigen
(PSA) level decreased from 5.62 ng/mL to 0.02 ng/
mL within 6 months after radiotherapy. Unfortunately,
pneumaturia, fecaluria and urine passage through the
rectum was noted 14 months after radiotherapy. A
prostatorectal fistula, with a diameter of about 2 cm
over the prostate urethra, was discovered by ureth-
rocystoscopy. Due to the patient’s advanced age and
medical history of coronary artery disease with recent
myocardial infarction, conservative treatments such as
suprapubic cystostomy and loop colostomy for urinary
and fecal diversion were performed. However, pain in
the anus after insertion of the suprapubic 26-Fr urethral
catheter developed. In addition, the patient suffered
from severe gross hematuria and intractable perineal
pain due to post-radiotherapy inflammatory changes
in the urinary bladder and rubbing of the bladder mu-
cosa by the tip of the urethral catheter. Massive bloody
urine extravasation from bladder to anus and colostomy
through the fistula was also noted.
We modified the urethral catheter by cutting the
catheter tip and trimming the cut margin smoothly
with inflation of 25 mL normal saline as a balloon to
prevent direct contact and rubbing of the catheter tip
with the bladder mucosa. After modification, gross he-
maturia and perineal pain improved. However, massive
urine extravasation from bladder to anus and colostomy
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persisted. Because the side hole along with the origi-
nal catheter tip was cut, poor drainage function of the
catheter was observed due to obstruction of the cen-
tral lumen. Therefore, we created another side hole
about 1 cm in length and 0.5 cm proximal to the bal-
loon edge on the opposite aspect of the balloon inflated
lumen to avoid injury of the inflated lumen and further
balloon leakage. To avoid urine leakage from the cen-
tral lumen of the cut Foley catheter tip, we occluded
the central lumen by insertion of a cut tip of another
14-Fr single-urethral catheter. In this way, urine could
be drained from the created side hole without leakage
through the distal central lumen of the Foley catheter
with the cut tip. The modified catheter was inserted into
the bladder with inflation of the balloon with 25 mL
normal saline and followed with a little forward insertion
to meet resistance. The inflated balloon was attached
to the bladder neck to avoid urine leakage through the
bladder neck to the fistula. To check the depth of the
inserted Foley catheter, a marker consisting of a 4-O
nylon suture was made about 3 cm from the side hole
(Figure 1). In addition, because the catheter was not
fixed on the abdominal wall by the catheter balloon,
as is common with a suprapubic urethral catheter, the
catheter was able to move outside or inside. The cath-
eter was kept in place by tape. After insertion of the
modified suprapubic catheter, only mild gross hema-
turia and retrograde urine extravasation from bladder
to the colostomy was noted, with only a slight effect
on the patient’s daily activities.
No tumor recurrence or symptomatic urinary tract
infection were noted during the follow-up period of
52 months. In follow-up imaging studies such as mag-
netic resonance imaging, the modified catheter was
properly indwelled, with the balloon placed just above
the bladder neck, occluding the urine-stream leakage
through the fistula (Figure 2). After the above modifi-
cations, the drainage function of the suprapubic catheter
(Figure 3) improved and the perineal pain and low
abdominal discomfort subsided. The patient’s quality
of life improved with only minimal pain medication
required.
Discussion
Rectourethral fistulae are a rare complication of treat-
ment for urinary or rectal malignancy or trauma.1 For
localized prostate cancer, radiotherapy is a known effec-
tive curative therapy. However, complications associated
with irradiation have been reported, and prostatorec-
tal fistulae were noted as one of the most troublesome
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Figure 1. Modification process of the suprapubic catheter. (A) Original 26-Fr 2-lumen Foley catheter and 14-Fr single catheterization
tube. (B) Foley catheter tip cut and cut margin trimmed; side hole created, about 0.5 cm from balloon and 1 cm in length, on opposite
side of inflated lumen; tip of 14-Fr single catheterization tube cut. (C) Cut tip of 14-Fr single catheterization tube inserted into distal 
central lumen of 26-Fr Foley catheter; 4-O nylon suture marker placed about 3 cm from created side hole (arrow indicates the created
side hole). (D) Modified catheter with inflation of 25 mL normal saline in balloon.
sequelae.2 Theodorescu et al reported incidence of
prostatourethral-rectal fistula in 1% of patients who
received brachytherapy for prostate cancer, 9–12 months
after treatment.3 Initial conservative treatment, such
as urinary and fecal diversion, is allowed for the possi-
ble spontaneous closure of fistulae in 3–6 months for
these patients. In patients without spontaneous closure
of fistulae, surgical treatment is indicated.4 However,
due to the difficulty of accessing the fistula and a high
rate of recurrence, surgery for rectourethral fistulae
remains a challenge. For patients who are not eligible
for surgical treatment, long-term suppressive antibiotics
are necessary to maintain asymptomatic status for years.5
For patients who have received suprapubic urinary diver-
sion, the indwelling catheter may cause discomfort,
pain and hematuria with urine leakage. The patient’s
quality of life is seriously impaired.6 Management of
the discomfort should be individualized.7,8
Our modified catheter provides less irritation to
the bladder mucosa and prevents urine extravasation
from the bladder to the prostatorectal fistula. Also,
because the catheter is not fixed, patients can adjust
the direction and depth of the catheter in the created
side hole as needed to achieve comfort. Some specially
designed urinary catheters have been commercially avail-
able for patients with irradiation complications such
as radiation cystitis and long-term suprapubic urethral
catheter indwelling, such as the 3-way 30 mL Bardex
Lubricath Latex Foley Catheter (Naegeli Model). Due
to the relatively high cost, however, such specially de-
signed catheters are less commonly applied in clinical
practice. Malecot tube has also been tried due to its
low price, but it is hard to use in the ward. In our case,
we modified the catheter using inexpensive and read-
ily available materials for a low-cost, highly acceptable
result. For patients with previous irradiation and prosta-
torectal fistulae with perineal or low abdominal pain,
hematuria, and urine extravasation from bladder to anus
and colostomy, our modified suprapubic catheter offers
a better diversion effect and better quality of life.
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Modified suprapubic catheter for prostatorectal fistula
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Figure 2. Magnetic resonance imaging (MRI) of the pelvis. (A) Modified catheter properly indwelled with balloon placed just above the
bladder neck, occluding the bladder neck and preventing urine leakage through the fistula (sagittal section). (B) Relative position of 











Figure 3. Illustration of the modified suprapubic catheter and
associated anatomy.
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